Browse By: Country ι Category ι Latest Reports ι Tag

Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

View Report Details
Description

Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region.  Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease.  The rheumatoid arthritis pharmacotherapeutics market is categorized as follows: Tumor Necrosis Factor (T... Click here for more details


Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies\' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes t
Published Date: Oct 2010
Price: $3500
Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns
GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre
Published Date: Oct 2010
Price: $3500
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in in
Published Date: Nov 2010
Price: $3500
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues re
Published Date: Dec 2010
Price: $3500
Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers
Published Date: Dec 2010
Price: $3500
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie
Published Date: Jan 2011
Price: $3500
Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth
GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market
Published Date: Apr 2011
Price: $3500
Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u
Published Date: Apr 2011
Price: $3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-
Published Date: May 2011
Price: $3500
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
GBI Researchs pharmaceutical report, ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders provides in-depth analysis of unmet needs, drivers and barriers that impact the global ENT disorders market. The report ana
Published Date: Apr 2011
Price: $3500

 


 

Related News

Construction of Canada Fiber Optic Plant: $50 Million Invested by China Fiber Optic
China Fiber Optic Network Systems Group Ltd. has contributed $50 million to set up a plant in Surrey, British Columbia, for the production of parts for China's fiber-optic correspondences system.  The plant is situated to utilize 200 individuals and is focused to be up and running in June to create $100 million value of fare deals to be taken back to China. The plant will be fabricating fired ferrule banks, the minute parts used to make fiber-optic wire connectors.  China Fiber i
Date: May 05

Comcast Q1 Earning Ascends on Cable Unit Pick Up
The cable giant, Comcast, whose endeavor to purchase Time Warner Cable was as of late suppressed. Monday, its first-quarter net salary climbed 10% to $2 billion as an increase in its Internet business balance and NBC Universal's income decrease.  In the wake of modifying few things, profit per share totaled 79 cents, fixing investigators' accord evaluation of 74 cents.  Companywide income climbed 2.6% to $17.9 billion.  Amid the first quarter, Comcast spent approximately $2
Date: May 05

Comprehensive Nepotism Unveiled at Chinese Telecommunications Firm
A large number of staff individuals at one of China's biggest telecommunications organizations had been conniving with their family and friends to run side organizations, benefitting off their parts at a state firm, as per the consequences of an as of late completed investigation.  Comrade Party agents set up shop in China Unicom before the end of last year, leading a swathe of meetings and poring over the organization's books. The move is a part of Party pioneer Xi Jinping's crusade to
Date: May 05

Chevrolet Revises the Price of the 2016 Volt for Greater Turnover
Chevrolet recently declared that it would be revising the prices of the latest model of the 2016 Volt. The question is whether or not the company will get a bigger pool of buyers who would be interested in purchasing this hybrid plug-in vehicle. The pricing of this vehicle is inclusive of the delivery charges thereby starting at a price of US$33995. This figure was disclosed by an email that the company had sent on Sunday.  This pricing involves a price cut that exceeded US$1000 as again
Date: May 05

How much can European Car Manufacturers Gain from the China Market?
A senior official at BMW stated that over the last couple of years, the company has not been earning favorable profits in the China market since the performance has not been very satisfactory. With a situation like this it has been quite difficult for the company to attain a certain contribution margin that it had almost three to four years back.  Several weeks later the German car manufacturer Audi stated that being a key market leader in the China automobile market it concluded that th
Date: May 05

Late Comers in the China Automobile Market to Benefit Hugely in the Long Run
Automobile brands such as Jaguar, Fiat, and Renault have entered quite late into the China automobiles market. This is one of the main factors that is making it difficult for these car brands to get established in the China market, which at present is in the economic doldrums. However, industry experts are stating that amidst all the economic issues and slowdown problems there are reasons for these car manufacturers to be positive and hopeful since most Chinese buyers exhibit very low degree of
Date: May 05

HDFC Raises Service Charges almost 50% on Debit Cards
The second largest bank in Indian private banking sector HDFC has increased service charges by almost 43% to 50% on selected products such as debit cards and immediate payment service (IMPS) as the bank focuses towards re-align its fee structure on par with competitors. HDFC customers will now have to pay US$11.79 for a platinum debit card of HDFC Bank against the existing annual fee of US$7.86, whereas a gold debit card would provide the same fee structure that is revised now, exclusive of appl
Date: May 04

China Starts Insurance System for Bank Deposits
China has started an insurance system for its over 100 trillion Yuan, that is around USS$21.3 trillion of the bank deposits on Friday, May 1, 2015 and the bond industry is preparing for the next step by now, that is, the end of the interest rate controls. The banks that hold the maximum of the corporate bonds in the second largest economy in the world are limited to paying 30% more than a standard deposit rate, at present. That cap is very expected to be done away with this year, the central
Date: May 04

ANZ Banking Group to get US$1.5 billion from Finance unit of Esanda
ANZ Banking Group has stated that it is planning to relieve of its Finance unit of Esanda, in an auction, which may generate offshore and local interest and watch the lender get leads in the order of US$1.5 billion.  The sale that is roughly half of the overall assets sitting under the wider Esanda arm exhibits US$8.3 billion in assets. In a statement issued on Monday, ANZ stated that the sale documents were due to be out later in this month. The 1st round of bids is estimated before the
Date: May 04

Strengthened Car Sales for Detroit Three May Face Headwinds
The auto makers in Detroit on account of best sales track since 2006 may want to gear up for harder times ahead. As per executives from the auto industry, the industry has been exhibiting healthy sales since its restructuring in 2009. Going by the recent performance of the of stock auto makers such as Ford Motor Co., General Motors Co., and Fiat Chrysler Automobiles NV, investors do not have a healthy view. In the last year, in spite of cash back policies to shareholders Ford and General Moto
Date: May 04

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795